欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/0612/001
药品名称
Grazax
活性成分
phleum pratense pollen allergen (extract) 75000.0 IU/ml
剂型
Oral lyophilisate
上市许可持有人
ALK-Abelló A/S Denmark
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
United Kingdom (Northern Ireland) (XI)
Portugal (PT)
Spain (ES)
France (FR)
Austria (AT)
Grazax 75.000 SQ-T - Lyophilisat zum Einnehmen
Ireland (IE)
Iceland (IS)
Luxembourg (LU)
Netherlands (NL)
Belgium (BE)
Denmark (DK)
Germany (DE)
Grazax
Romania (RO)
Czechia (CZ)
Bulgaria (BG)
Grazax
Croatia (HR)
Lithuania (LT)
GRAZAX 75 000 SQ-T geriamasis liofilizatas
Latvia (LV)
Estonia (EE)
Slovenia (SI)
Slovakia (SK)
GRAZAX
Poland (PL)
GRAZAX
Italy (IT)
Finland (FI)
Hungary (HU)
Grazax
Norway (NO)
许可日期
2006/09/25
最近更新日期
2024/01/12
药物ATC编码
V01AA02 grass pollen
申请类型
TypeLevel1:
Known Active Substance
TypeLevel2:
Initial Application
TypeLevel3:
Full Dossier Art 8.3(i) Dir 2001/83/EC
TypeLevel4:
Biological: Other
TypeLevel5:
Prescription Only
附件文件下载
Final PL
|
SE/H/0612/001_Final PL
Date of last change:2014/01/15
Final SPC
|
SE/H/0612/001_Final SPC
Date of last change:2014/01/15
PAR
|
SE/H/0612/001_PAR
Date of last change:2014/01/15
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase